Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Decitabine and cedazuridine

Drug name(s)

Inqovi® Decitabine and cedazuridine

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Myelodysplastic Syndromes (MDS)

Enasidenib

Drug name(s)

Idhifa® Enasidenib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Fedratinib

Drug name(s)

Inrebic® Fedratinib

Approved for

  • Essential Thrombocythemia
  • Primary Myelofibrosis
  • Polycythemia Vera

Ibritumomab tiuxetan

Drug name(s)

Zevalin® Ibritumomab tiuxetan

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)

Ibrutinib

Drug name(s)

Imbruvica® Ibrutinib

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Waldenström Macroglobulinemia (WM)
  • Other Blood Cancers

Idarubicin

Drug name(s)

Idamycin® Idarubicin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Idecabtagene vicleucel

Drug name(s)

Abecma® Idecabtagene vicleucel

Approved for

  • Myeloma

Idelalisib

Drug name(s)

Zydelig® Idelalisib

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)

Ifosfamide

Drug name(s)

Ifex® Ifosfamide

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)

Imatinib mesylate

Drug name(s)

Gleevec® Imatinib mesylate

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Chronic Eosinophilic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Other Blood Cancers

Imetelstat

Drug name(s)

Rytelo Imetelstat

Approved for

  • Myelodysplastic Syndromes (MDS)

Inotuzumab Ozogamicin

Drug name(s)

Besponsa® Inotuzumab Ozogamicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Interferon alfa-2a

Drug name(s)

Roferon®-A Interferon alfa-2a

Approved for

  • Chronic Myeloid Leukemia (CML)
  • Hairy Cell Leukemia (HCL)
  • Other Blood Cancers

Interferon alfa-2b

Drug name(s)

Intron® A Interferon alfa-2b

Approved for

  • Leukemia
  • Hairy Cell Leukemia (HCL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Follicular Lymphoma (FL) 
  • Polycythemia Vera

Isatuximab-irfc

Drug name(s)

Sarclisa® Isatuximab-irfc

Approved for

  • Myeloma

Ivosidenib

Drug name(s)

Tibsovo® Ivosidenib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)

Ixazomib

Drug name(s)

NINLARO® Ixazomib

Approved for

  • Myeloma

Ponatinib

Drug name(s)

Iclusig® Ponatinib

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML)

Romidepsin

Drug name(s)

Istodax® Romidepsin

Approved for

  • Lymphoma
  • Cutaneous T-cell Lymphoma (CTCL)

Can’t find what you’re looking for?
Contact a Blood Cancer United Information Specialist.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.